$SMNR

$0.50 -$0.05 (9.02%) Close

$SMNR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 230.2M shares outstanding

Who owns SMNR?

By type of holder

Institutions 0.0% Insiders 78.9% Everyone else 21.1%

Concentration Top 2 holders own 154.8%

Scilex Holding Company 78.9% · Scilex, Inc. 75.9%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Semnur Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+2.4%

+2.39% a year

Each share's claim on the business

−2.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$43.4M vs $143M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding SMNR.

Super Investors

Investment managers reporting SMNR on Form 13F

No 13F manager reports holding SMNR yet.

Institutional Funds

Mutual funds and ETFs reporting SMNR on Form N-PORT; together they hold 0.2% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
CM Calamos Market Neutral Income Fund Calamos Investment Trust/il	$27.7K	350.0K	0.15%	0.00%	July 31, 2026
SC Saba Capital Income & Opportunities Fund Saba Capital Income & Opportunities Fund	$2.18K	—	0.00%	0.00%	July 31, 2026

Calamos Market Neutral Income Fund

Calamos Investment Trust/il

Position value

$27.7K

% of company

0.15%

% of the fund

0.00%

As of

July 31, 2026

Saba Capital Income & Opportunities Fund

Position value

$2.18K

% of company

0.00%

% of the fund

0.00%

As of

July 31, 2026

1 more funds behind a free account

See every fund holding Semnur Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SH Scilex Holding Company 5%+ holder 13D · 78.9%	181.5M	78.85%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company78.850% Disclosed stake13D · 78.9% View the 13D/G filing →
S Scilex, Inc. 5%+ holder 13D · 75.9%	174.8M	75.92%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company75.920% Disclosed stake13D · 75.9% View the 13D/G filing →

Scilex Holding Company

5%+ holder13D · 78.9%

181.5M

% of company

78.85%

Change vs last qtr

—

Held since

—

Scilex, Inc.

5%+ holder13D · 75.9%

174.8M

% of company

75.92%

Change vs last qtr

—

Held since

—

Comments